Genetic Engineering is Challenging What We Know about Life and Disease

Bouvier Meijgaarden^*
*Correspondence: Bouvier Meijgaarden, Department of Biological Chemistry, University of Oxford, Oxford OX1 3BW, UK, Email:

Introduction

Genetic engineering, also known as genetic modification or gene editing, has emerged as one of the most revolutionary fields in modern science. This advanced technology allows scientists to directly manipulate an organism's genes by altering its DNA. Initially, the concept of changing genetic material might have sounded like something out of science fiction, but with breakthroughs such as CRISPR-Cas9 and other gene-editing tools, genetic engineering has become a reality. Its potential to reshape medicine, agriculture, and even the way we understand life itself is immense. However, this power comes with ethical, social, and biological challenges that are constantly evolving. Genetic engineering has opened the doors to unprecedented opportunities, particularly in the fields of medicine and disease treatment. It allows for the possibility of curing previously untreatable genetic disorders, enhancing human capabilities, and even potentially designing organisms with specific traits. But it also challenges our foundational understanding of life and disease. For centuries, we have operated under the belief that our genetic makeup is a fixed and largely unchangeable aspect of biology. Genetic engineering not only challenges this concept but also raises important questions about what it means to be human and how much control we should have over lifeâ??s fundamental building blocks [1].

Description

At its core, genetic engineering involves altering the genetic material of an organism-be it bacteria, plants, animals, or humans-in ways that would not naturally occur through reproduction or natural processes. This is achieved by directly manipulating the DNA, the molecular structure that carries genetic information. The techniques of genetic engineering allow scientists to add, delete, or modify genes to produce desired characteristics in an organism. One of the most significant developments in genetic engineering has been the advent of the CRISPR-Cas9 gene-editing technology. This tool, discovered in bacteria as a defense mechanism against viruses, allows scientists to cut and edit specific DNA sequences with high precision. Since its discovery, CRISPR has revolutionized genetic engineering, making it more accessible and efficient. Unlike earlier methods that were much more cumbersome and imprecise, CRISPR allows for precise targeting and modification of genetic sequences, which has opened up vast new possibilities for research and treatment. Gene editing technologies such as CRISPR, ZFNs (zinc finger nucleases), and TALENs (Transcription Activator-Like Effector Nucleases) are making it easier to manipulate genes in living organisms. For example, these technologies can be used to "edit" the human genome by correcting genetic mutations responsible for diseases, such as cystic fibrosis, sickle cell anemia, and Duchenne muscular dystrophy. Gene editing can potentially be used to "repair" genes that are faulty, offering hope for a future where genetic diseases can be prevented or cured altogether [2,3]..

Perhaps the most exciting area in which genetic engineering is making a dramatic impact is in the field of medicine. The ability to manipulate genes directly holds the promise of eradicating or alleviating a wide range of genetic disorders. For instance, gene therapy has already been used experimentally to treat certain inherited diseases, and clinical trials for genetic treatments are rapidly increasing. One of the most notable examples of gene therapy is the treatment of inherited blindness. In 2017, the first FDA-approved gene therapy for an inherited disease, called Luxturna, was made available to patients with a form of inherited retinal disease. This therapy uses a virus to deliver a healthy copy of the RPE65 gene to the retina, restoring vision in some patients. It was a monumental moment for the field of genetic engineering and raised hope for the potential to treat a variety of other diseases. In addition to gene therapy, genetic engineering has the potential to enhance the human body's natural abilities. Scientists have already created genetically modified organisms (GMOs) in agriculture, and the concept of genetically modifying humans for specific purposes is now part of the conversation. Though controversial, the possibility of engineering humans for increased intelligence, resistance to diseases, or other enhanced traits is an area of ongoing research [4].

CRISPR technology has also been used to create genetically modified immune cells, specifically T cells that can target and destroy cancer cells. The CRISPR-Cas9 system is employed to enhance the immune systemâ??s ability to fight diseases, particularly cancer. In a clinical trial for treating cancers like leukemia, researchers edited T-cells to attack cancer cells more effectively. The results from some trials have been promising, showing that genetic modifications could lead to more effective cancer treatments with fewer side effects compared to traditional therapies like chemotherapy. Another groundbreaking area is the potential to correct genetic mutations in embryos. This concept, while still heavily regulated and debated, could pave the way for eliminating genetic diseases before birth. By using gene-editing technologies like CRISPR to remove or repair harmful mutations, scientists could theoretically prevent certain congenital diseases from being passed down through generations. However, this raises numerous ethical concerns, especially around the idea of creating "designer babies" with specific genetic traits. Beyond human health, genetic engineering is also transforming agriculture. By altering the DNA of crops, scientists have developed genetically modified plants that are resistant to pests, drought, and diseases. These advancements can lead to higher crop yields, less dependence on chemical pesticides, and greater food security, especially in areas prone to famine or climate change. Genetically engineered crops such as Bt corn, which contains a gene from the bacterium Bacillus thuringiensis that makes it resistant to certain pests, have been widely adopted in many parts of the world [5].

Conclusion

Genetic engineering is one of the most transformative and controversial technologies of the 21st century. With the ability to directly manipulate the genetic code of living organisms, it challenges our basic understanding of life and disease. From revolutionizing medicine and offering the possibility of curing genetic disorders to reshaping agriculture and addressing global hunger, genetic engineering offers immense potential for improving human well-being. However, it also raises profound ethical, social, and environmental questions that we must grapple with as we move forward. As genetic engineering continues to evolve, it will undoubtedly change the way we think about life, health, and the future of humanity. The technology has the potential to offer groundbreaking solutions to some of the most pressing problems facing the world today. But it also forces us to confront fundamental questions about the nature of life, the limits of human intervention, and the ethical boundaries of science. The future of genetic engineering will depend not only on scientific progress but also on our collective ability to navigate the complex ethical and social challenges it presents.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Murray, Susan E., Pavlo A. Nesterenko, Adam L. Vanarsdall and Michael W. Munks, et al. "Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans." World J Exp Med 214 (2017): 1889-1899.

Google Scholar    Cross Ref    Indexed at

2. Watkins, David I., Mari Kannagi, Marc E. Stone and Norman L. Letvin. "Major histocompatibility complex class I molecules of nonhuman primates." Eur J Immunol 18 (1988): 1425-1432.

Google Scholar    Cross Ref    Indexed at

3. Hill, Ann B. "The immune response to CMV infection and vaccination in mice, monkeys and humans: Recent developments." Curr Opin Virol 28 (2018): 161-166.

Google Scholar    Cross Ref    Indexed at

4. Adler, Stuart P., Anne-Marie Manganello, Ronzo Lee and Michael A. McVoy, et al. "A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimera vaccines in cytomegalovirus–seronegative men." J Infect Dis 214 (2016): 1341-1348.

Google Scholar    Cross Ref    Indexed at

5. Hansen, Scott G., Jennie L. Womack, Wilma Perez and Kimberli A. Schmidt, et al. "Late gene expression–deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV." JCI Insight 8 (2023): e164692.

Google Scholar    Cross Ref    Indexed at